Joseph S. Freedman - 13 Mar 2026 SCHEDULE 13D/A Report for Eupraxia Pharmaceuticals Inc. Common Shares, no par value (EPRX)

Filing Manager: Joseph S. Freedman
Reporting Manager: Joseph S. Freedman
Security: Eupraxia Pharmaceuticals Inc. Common Shares, no par value
Symbol: EPRX
Shares outstanding: 64,924,611 shares
Disclosed Ownership: 5,843,215 shares
Ownership: 9%
Form type: SCHEDULE 13D/A
Filing time: 16 Mar 2026, 21:56:43 UTC
Date of event: 13 Mar 2026
Previous filing: 26 Sep 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Joseph S. Freedman	9%	5,843,215	4,309,205	1,534,010	/s/ Joseph S. Freedman	Joseph S. Freedman	0002043590